• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
214.53 -6 (-2.81%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    212.01

  • Today’s High

    231.00

  • Open

    221.51

  • Perv Close

    220.74

  • 52W Low

    146.25

  • 52W High

    261.00

Key Indicators

  • P/E(TTM)

    61.81

  • Mar.Cap (₹Cr.)

    2,645.17

  • Div & Yield %

    0.28

  • Book Value(₹)

    97.24

  • Debt-Equity Ratio

    -2.81

  • AGM Date

    03-Nov-2026

  • EPS

    3.46

  • P/E Ratio

    61.81

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    2,645.17

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    97.20

  • Sales( ₹ in Cr.)

    1,712.60

  • NP (in Cr.)

    27.30

  • NP Var(%)

    -70.0

  • Div%

    30.0

  • CPS (₹)

    15.50

  • EPS (₹)

    2.20

  • Traded Value (₹ in Lakhs)

    2,720.63

  • 52 Week High

    261.00

  • 52 Week Low

    146.25

  • Price BSE

    221.0

  • Price NSE

    221.00

  • Market Capital( in Cr.)

    2,720.63

  • P/C Ratio

    14.30

  • P/E Ratio

    99.80

  • Price Vs.BV

    2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,712.60 1,859.80 1,784.60 2,023.03 1,942.72 1,720.44
Other Income 12.30 5.00 2.50 5.41 4.89 4.98
Stock Adjustments 36.90 45.30 -19.50 14.56 35.82 -1.67
Total Income 1,761.80 1,910.10 1,767.60 2,043.00 1,983.43 1,723.75
EXPENDITURE :            
Raw Materials 798.60 882.60 805.20 1,121.59 1,032.21 906.71
Power and Fuel Cost 169.80 168.10 170.20 186.91 175.46 147.83
Employee Cost 266.00 242.30 244.00 220.40 201.35 164.32
Other Manufacturing Expenses 132.40 141.50 136.50 114.60 106.37 91.27
Selling and Administration Expenses 130.00 115.20 116.20 110.01 101.31 64.05
Miscellaneous Expenses 117.30 26.90 26.10 27.02 21.28 21.71
Employee Benefit Expenses 266.00 242.30 244.00 220.40 201.35 164.32
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,614.10 1,576.60 1,498.20 1,780.53 1,637.98 1,395.88
Operating Profit 147.70 333.50 269.40 262.47 345.46 327.87
Interest 62.10 75.20 56.40 48.10 31.22 36.20
Gross Profit 85.60 258.30 213.00 214.37 314.24 291.67
Depreciation 163.80 134.40 117.60 109.01 95.67 85.25
Profit Before Tax -78.20 123.90 95.40 105.36 218.57 206.42
Current Tax -2.00 30.00 28.40 30.48 59.65 79.55
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -27.50 3.00 -2.50 -3.49 -1.59 -6.27
Reported Net Profit -48.70 90.90 69.50 78.38 160.51 133.14
Extraordinary Items -76.00 0.63 0.42 0.45 0.14 0.01
Adjusted Net Profit 27.30 90.27 69.08 77.93 160.37 133.13
Adjustment below Net Profit -2.20 -1.40 -0.70 -0.60 1.19 -1.44
P & L Balance brought forward 998.60 924.00 870.00 804.60 670.03 553.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 12.30 14.90 14.80 12.33 27.13 14.80
P & L Balance carried down 935.40 998.60 924.00 870.05 804.60 670.03
Dividend 2.40 0.00 0.00 0.00 0.00 12.33
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 70.00 60.00 60.00 80.00 100.00
Dividend Per Share(Rs) 0.60 1.40 1.20 1.20 1.60 2.00
Earnings Per Share-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Earnings Per Share(Adj)-Unit Curr -3.94 7.36 5.63 6.36 13.02 10.80
Book Value 97.09 102.20 96.16 91.93 86.62 75.70
Book Value(Adj)-Unit Curr 97.09 102.20 96.16 91.93 86.62 75.70

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,082,600 9.80 12,082,600 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 637,500 0.52 637,500 7
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,571,824 1.27 1,571,824 37
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 6,278,785 5.09 6,278,785 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 275,000 0.22 275,000 2
Trusts 500 0.00 500 1
Venture Capital Funds 0 0.00 0 0
Sub total 8,126,359 6.59 8,126,359 45
2] Non Institution
Bodies Corporate 1,979,916 1.61 1,979,916 301
Clearing Members 151,683 0.12 151,683 29
Directors of their Relatives 450,976 0.37 450,976 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,119,908 1.72 2,119,908 1,500
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,278,899 1.04 1,278,899 1,480
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,191,344 2.59 3,191,344 13
Individuals holding nominal share capital up to Rs. 1 lakh 20,605,049 16.71 20,495,218 71,367
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,513 0.02 18,513 1
Others 419,913 0.34 419,913 6
Sub Total 30,281,625 24.56 30,171,794 74,722
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2 0.00 2 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2 0.00 2 1
Grand Total ( A + B + C ) 123,300,750 100.00 123,190,919 74,785

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    J Hiremath

  • Managing Director

    Sameer Hiremath

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 213.85 1,724.90 1,712.60 -78.62 3.35
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77